Sign in
CRRTF Stock Price, Chart, Stats & News
Crescita Therapeutics, Inc.
Save
Crescita Therapeutics, Inc. (CRRTF) does not currently pay a dividend.
10.40M
Market cap
–
Current P/E
–
Forward P/E
CRRTF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. It operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The company owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers and DuraPeel that supports the development of patented formulations to facilitate the delivery of active ingredients into or through the skin.
Similar securities
Based on sector and market capitalization
Report issue